Table 3.
Comorbidities. LSG – laparoscopic sleeve gastrectomy. OAGB – one anastomosis gastric bypass. RYGB – Roux-en-Y gastric bypass. BMI – body mass index. WBC – white blood count. DM2 – diabetes mellitus type 2. HT – hyper-tension. OSAS – obstructive sleep apnea syndrome. DL – dyslipidemia. GERD – gastroesophageal reflux disease
| Comorbidities | RYGB (n = 33) | OAGB (n = 47) | p value |
|---|---|---|---|
| DM2 before LSG n (%) | 10 (30%) | 16 (34%) | 0.811 |
| DM2 before conversion | 6 (18%) | 12 (25.5%) | 0.588 |
| DM2 after conversion | 4 (12%) | 1 (2%) | 0.026 |
| DM2 remissions n (%) | 2 (33%) | 11 (91.7%) | 0.035 |
| HT before LSG | 13 (39%) | 25 (53%) | 0.261 |
| HT before conversion | 10 (10%) | 22 (47%) | 0.168 |
| HT after conversion | 7 (21%) | 16 (34%) | 0.3157 |
| HT remissions n (%) | 3 (30%) | 6 (27.3%) | 0.729 |
| OSAS before LSG | 3 (9%) | 5 (11%) | > 0.999 |
| OSAS before conversion | 1 (3%) | 5 (11%) | 0.392 |
| OSAS after conversion | 0 | 2 (4%) | 0.509 |
| OSAS remissions n (%) | 1 (100%) | 3 (60%) | 0.639 |
| DL before LSG | 6 (18%) | 23 (49%) | 0.005 |
| DL before conversion | 6 (18%) | 22 (47%) | 0.010 |
| DL after conversion | 1 (3%) | 9 (19%) | 0.041 |
| DL remissions n (%) | 5 (83.3%) | 13 (59.1%) | 0.277 |
| GERD before LSG | 5 (15%) | 8 (17%) | > 0.999 |
| GERD before conversion | 10 (30%) | 7 (15%) | 0.16 |
| GERD after conversion | 6 (18%) | 9 (19%)* | > 0.999 |
| GERD remissions n (%) | 4 (40%) | 5 (71.4%) | > 0.999 |
*7 newly diagnosed cases of reflux not seen before conversion